In addition to that, tumor progression is supported by a mutation in either succinate dehydrogenase complex (SDH) or fumarate hydratase (FH) enzymes which have antitumor effects in hereditary tumor syndromes (183–185). The gene discussed is FH; the disease is hereditary neoplastic syndrome.